Int J Sports Med 2024; 45(11): 791-803
DOI: 10.1055/a-2296-7604
Review

Cardiomyocyte Adaptation to Exercise: K+ Channels, Contractility and Ischemic Injury

Robert H. Fitts
1   Biological Sciences, Marquette University, Milwaukee, United States
,
Xinrui Wang
2   Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, United States
3   Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States
,
Wai-Meng Kwok
2   Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, United States
3   Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States
4   Anesthesiology, Medical College of Wisconsin, Milwaukee, United States
5   Cancer Center, Medical College of Wisconsin, Milwaukee, United States
,
Amadou K. S. Camara
3   Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States
4   Anesthesiology, Medical College of Wisconsin, Milwaukee, United States
5   Cancer Center, Medical College of Wisconsin, Milwaukee, United States
6   Physiology, Medical College of Wisconsin, Milwaukee, United States
› Author Affiliations
 

Abstract

Cardiovascular disease is a leading cause of morbidity and mortality, and exercise-training (TRN) is known to reduce risk factors and protect the heart from ischemia and reperfusion injury. Though the cardioprotective effects of exercise are well-documented, underlying mechanisms are not well understood. This review highlights recent findings and focuses on cardiac factors with emphasis on K+ channel control of the action potential duration (APD), β-adrenergic and adenosine regulation of cardiomyocyte function, and mitochondrial Ca2+ regulation. TRN-induced prolongation and shortening of the APD at low and high activation rates, respectively, is discussed in the context of a reduced response of the sarcolemma delayed rectifier potassium channel (IK) and increased content and activation of the sarcolemma KATP channel. A proposed mechanism underlying the latter is presented, including the phosphatidylinositol-3kinase/protein kinase B pathway. TRN induced increases in cardiomyocyte contractility and the response to adrenergic agonists are discussed. The TRN-induced protection from reperfusion injury is highlighted by the increased content and activation of the sarcolemma KATP channel and the increased phosphorylated glycogen synthase kinase-3β, which aid in preventing mitochondrial Ca2+ overload and mitochondria-triggered apoptosis. Finally, a brief section is presented on the increased incidences of atrial fibrillation associated with age and in life-long exercisers.


Introduction

Cardiovascular disease is a leading cause of morbidity and mortality worldwide, and exercise-training (TRN) is known to be effective in countering cardiovascular risk factors, reducing the incidences and severity of ischemic heart disease, and protecting against heart failure [1] [2] [3]. The beneficial effects of TRN are mediated by both organ and system adaptations that reduce the relative workload of daily living, such as increased cardiac output, improved tissue blood flow regulation, and increased maximal oxygen uptake, and direct cellular adaptations that improve heart function and reduce diseases of the heart. These include improved coronary circulation, enhanced contractility, increased left ventricular end diastolic dimension, elevated myofibrillar Ca2+ sensitivity, improved metabolic efficiency, and altered electrical properties of the heart [4] [5] [6] [7] [8] [9] [10]. This review will focus on cardiac factors considering how TRN affects surface membrane receptors, membrane channels, excitation-contraction coupling, and mechanical properties of cardiomyocytes. We will also consider 1) a comparison of moderate and high intensity TRN; and 2) TRN effects on diseases of the heart with special emphasis on ischemic heart disease and arrhythmias.


Importance of moderate versus intense exercise

A question of considerable interest to the public is how much exercise is enough to generate cardiovascular protection, and is moderate exercise enough or do exercise programs require some degree of intense exercise. This topic has been recently reviewed in detail [11] [12] and is reviewed only briefly here. TRN programs can be defined as those primarily employing moderate-intensity continuous exercise-training (MICT) utilizing work loads of approximately 60 to 75% of heart rate (HR) peak or high-intensity interval training (HIIT) generally at 85 to 95% of HR peak [13] [14]. Arguments favoring a component of HIIT stem in part from the observation that it generates a greater increase in aerobic power than MICT in both healthy and cardiovascular patients. This is particularly important to the latter group as low aerobic power has been reported to be the best predictor of cardiac and all caused death among these patient groups [12] [14]. Additionally, in cardiac patients HIIT increases left ventricular ejection fraction and isovolumetric relaxation time factors unaffected by MICT [11] [12] [14] [15] [16]. HIIT is also more effective in reducing exercise blood pressure and norepinephrine levels, which would contribute to a reduction in blood pressure [11] [17]. At the cell level, HIIT has been shown to cause a greater increase in shortening rate than MICT an effect that would contribute to the TRN-induced increase in stroke volume [18]. Additionally, HIIT requires less exercise time than MICT for similar health benefits [11] [12]. Nonetheless, for many cardiovascular risk factors, such as resting blood pressure and heart rate, and blood glucose and lipid control, HIIT does not outperform MICT [12]. Adherence to TRN is also a consideration and this appears higher with MICT than HIIT [11]. Another concern is that HIIT is associated with a greater number of life-threatening events [12] [15]. For healthy individuals of all ages, incorporating a HIIT component into a TRN program is important for optimal health gains [13] [14]. The published literature suggests that HIIT offers advantages over MICT for cardiovascular patients as well, but the optimal protocol for improving cardiovascular function and the risk to benefit ratio needs further investigation for this population group [11] [12].


TRN induced adaptations in cardiac action potential

Regulation of the cardiac action potential duration (APD) during rest and exercise is important to ensure adequate Ca2+ influx while preventing Ca2+ overload, excess ionic pump activity (Na+-K+ and SR Ca2+ pumps) and/or inadequate time for relaxation [7]. It is well known that transmural differences exist in the AP shape with cardiomyocytes (CMs) in the base region of the heart (dominated by endocardial CMs) showing longer durations compared to the apex region (dominated by epicardial CMs) ([Fig. 1]) [6] [19] [20] [21] [22]. Regulation of the various sarcolemma K+ channels seems particularly important in controlling APD [7] [23]. The most relevant K+ channels are as follows: the rapidly activating, transient Ito channel that generates the early repolarization preceding the AP plateau; the delayed rectifier channel IK, which consists of two Kv (voltage-gated) channel isoforms; a rapidly activating IKr and a slowly activating IKs, and the KATP channel as they regulate the duration of the action potential plateau and thus Ca2+influx, and in animals all three have been shown to be altered by programs of exercise-training [6] [7] [19] [24] [25]. With low activation rates (1 Hz) up to rates observed in resting rat hearts (5 Hz), we showed that a type of MICT (wheel running in rats) prolonged the CM APD while regional differences base+>+apex were maintained ([Fig. 1]). However, at CM stimulation rates simulating heavy exercise (10 Hz), APD is reduced with greater reductions in CMs isolated from TRN compared to sedentary (SED) animals ([Fig. 2]) [19]. These adaptations in the APD are important for improving the efficiency of the heart at rest (i. e. lower heart rate) and during exercise (reduced energy requirement for ion homeostasis), and for preserving time for cardiac relaxation and venous return during exercise. The TRN-induced prolongation of the APD at low CM stimulation rates (1 to 5 Hz) is in part mediated by a downregulation in the response to β-adrenergic receptor (β-AR) agonist causing inhibition of the Ito and reduced activation of the delayed rectifier (Ik) [6] [25] [26]. The observation that this effect was observed in isolated CM suggests that TRN also directly inhibited K+ channel function. In unstressed CM, the primary repolarizing current is carried by the Ik, where the relative importance of the two major isoforms is species dependent [27] [28] [29]. In rat CMs, the Iks is relatively more important than the Ikr [25], and recently we showed TRN to reduce channel protein (KCNQ1 and KCNE1) content and current density of the Iks and the kinase anchoring protein Yotiao, a protein required for the PKA phosphorylation of IKs [25]. This TRN-induced down regulation of the Iks channel and Yotiao provides a mechanism for the reduced responsiveness of the action potential to β-AR agonists despite no change in adrenergic receptor content ([Fig. 3]) [25] [26]. The reduced Yotiao content would reduce PKA phosphorylation of the pore forming Iks subunit KCNQ1, which accounts for most of the functional modulation of Iks by the sympathetic nervous system [30]. It is not known whether TRN downregulates the delayed rectifier channel in human cardiac muscle, but the known exercise-training induced reduction in resting heart rate in humans is consistent with a delayed onset of action potential repolarization and outward K+ current. Human ventricles have higher Ikr current than Iks so a TRN downregulation in the latter may be less important [31]. However, at heart rates higher than resting, the rapidly activating Ikr channel may become inactivated, increasing the importance of the Iks channel to repolarization and the APD even in human CM [31]. The higher content of the pore forming subunit KCNQ1 of the Iks in the apex region compared to the base region of the heart explains the greater APD observed in CM base ([Fig. 1]). This regional difference in Iks content is important as it allows the endocardium while depolarizing first to repolarize after the epicardium facilitating ventricular ejection and reducing the likelihood of arrhythmias caused by premature excitation of the endocardium [32].

Zoom
Fig. 1 Overlapping representative action potential traces from apex and base myocytes in sedentary (SED) and exercise-trained (TRN) female rats. Action potential durations (APD) measured at 90% repolarization of the action potential (APD90) in apex and base myocytes show a regional difference, with APD90 of base myocytes (representative of endocardial cells) significantly longer than apex myocytes (representative of epicardial cells). The APD90 values for both are significantly prolonged by exercise training. Measurements were obtained at room temperature with 1-Hz stimulation.
Zoom
Fig. 2 Representative action potential traces highlighting high stimulation rate (10 Hz) induced shortening of action potential duration (APD) measured at 90% repolarization of the action potential (APD90) compared to 1 Hz stimulation (left) and exercise-training effect at 10 Hz (right). At 10 Hz, APD90 was shortened more in myocytes from exercise-trained (TRN) than sedentary (SED) rats.
Zoom
Fig. 3 Schematic of key cardiomyocyte components, including the sarcolemma, myofibrils, sarcoplasmic reticulum, and mitochondria, and adaptations with exercise-training (TRN). Downward and upward arrows indicate a TRN-induced decrease and increase, respectively, in proteins or physiological conditions. The downward arrows for ICa,L and cytosolic Ca2+ refer to less of an increase in TRN compared to sedentary (SED) during stress. Abbreviations: AP, action potential; IKATP, outward repolarizing potassium current through the KATP channel; IKS, outward repolarizing potassium current through the slowly activating, delayed rectifier potassium channel; ICa,L, current thru the L-type Ca2+ channel; A1, A2a, A2b, A3; adenosine receptor isoforms; β1, beta adrenergic receptor; Gs, stimulatory G protein; Gi, inhibitory G protein; GRK2, G-protein-coupled receptor kinase 2; PKA, protein kinase A; AMPK, AMP-activated protein kinase; pGSK3β, phosphorylated glycogen synthase kinase-3β; pAkt, phosphorylated protein kinase B; VDAC1, voltage dependent anion channel 1; GRP75, glucose-regulated protein 75; SERCA, sarco/endoplasmic reticulum Ca2+ ATPase pump; MyBP-C, myosin binding protein C; RLC, regulatory light chain; IP3R, IP3 receptor. Figure created using Microsoft PowerPoint.

TRN-induced upregulation and activation of the sarcolemma KATP channel

Recently, we observed TRN to increase sarcolemma KATP (sKATP) channel content in CM isolated from both the apex and base regions of the heart; however, regional differences existed with TRN upregulating the Kir6.2 and SUR2A subunits in apex and base CM, respectively [22]. The greater reduction in CM APD at high stimulation rates in TRN compared to SED was associated with an increased sKATP repolarization current, an effect at least in part caused by a TRN-induced increase in sKATP channel content [7] [19] [22] [33]. In support of this conclusion, the greater decrease in the APD with high CM stimulation (10 Hz) following TRN was blocked by glibenclamide, a sKATP channel blocker [7] [19]. Additionally, pinacidil, a sKATP channel activator, shortened the APD more in CM from TRN than SED rats and in the presence of pinacidil, 10 Hz stimulation had no additional effect on the APD than pinacidil plus 1 Hz stimulation [22].

TRN increases in the sKATP channel content and shifts the primary control of action potential repolarization during high activation rates (i. e. exercise) from the Ik channel to the metabolically controlled sKATP channel ([Fig. 3]). At rest, the channel is inhibited by nonhydrolytic binding of ATP an effect relieved during exercise by the elevated metabolic demand causing reduced ATP/ADP and ATP/AMP ratios [34] [35] [36]. The TRN-induced increase in the sKATP channel allows for rapid beat to beat control of heart APD in response to changes in cell metabolism, which should result in a more optimal match of cell activation (i. e. intracellular Ca2+ influx), contractility, and HR leading to a more efficient heart. While it is known that the sKATP channel is activated with exercise and with ischemia and reperfusion (IR), the mechanism of activation is not well understood [37]. A decline in the ATP/ADP and ATP/AMP ratios likely contribute to sKATP channel activation with exercise; however, that is unlikely to be the only mechanism or explain the elevated activity following TRN. A prime candidate for the observed TRN-induced activation of the channel is the phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt) pathway. It is well established that TRN increases growth hormone and insulin-like growth factor (IGF-1) leading to an activation of phosphatidylinositol-3-kinase (PI3K), which phosphorylates phosphatidylinositol bisphosphate (PIP2) to triphosphate (PIP3). The PIP3 in turn phosphorylates Akt [38]. The ATP inhibition of the sKATP channel is partially blocked by PIP3 [36] [38]. Importantly, PIP3 is known to activate 3-phosphoinositide-dependent kinase 1 (PDKI), which phosphorylates itself and Akt. Phosphorylated Akt (pAkt), the active form of the protein, can detach from PIP3 and activates multiple cytosolic proteins, including glycogen synthase kinase-3β (pGSK3β) [39], and the mammalian target of rapamycin (mTOR), which has been implicated in the TRN-induced physiological cardiac hypertrophy [9] [38]. While there is no evidence that the mTOR pathway has any effect on the sKATP channel, it has been reported that GSK3β promotes sKATP channel closing, an activity inhibited by pGSK3β [40] [41]. Importantly, TRN has been shown to cause a 2.5-fold increase in pGSK3β [39]. Consequently, the TRN-induced activation of the sKATP channel with exercise may be in part caused by activation of the PI3K-Akt-GSK3β pathway ([Fig. 3]). Activation of this pathway might be facilitated by brain-derived neurotrophic factor (BDNF) as this protein has been shown to increase with swim exercise-training in mice and activate PI3K-Akt [42] [43].

Due to its importance, activation of the sKATP channel with stress (cardiac ischemia or exercise) is likely controlled by multiple factors. Besides the PI3K-Akt-GSK3β pathway, there is evidence that activation of AMP-activate protein kinase (AMPK) may play a role [37] [44]. AMPK is known to physically interact with the sKATP channel, and with stress AMPK activation via phosphorylation (pAMPK) by upstream kinases (AMPKKs) promotes channel opening [44] [45]. With exercise, AMP increases and binds to AMPK, which reduces ATP inhibition of AMPK and makes it a better substrate for AMPKKs, which increases pAMPK [46]. Importantly, TRN is known to increase pAMPK, which might contribute to the TRN-induced activation of the sKATP channel ([Fig. 3]) [46] [47]. While not proven, it is possible that the TRN upregulation of the sKATP channel in the heart could play an important metabolic role in addition to its regulation of the APD and Ca2+ influx by upregulating glucose uptake and mitochondrial biogenesis, and increasing glucose metabolism during stress a role that might be enhanced by pAMPK [37] [46] [47]. The idea that the sKATP channel plays an important metabolic role is supported by the observation that channel activation increases PGC-1α expression, a transcriptional coactivator known to stimulate mitochondrial biogenesis [48].

Adenosine may be important in TRN-induced increases in the sKATP channel. Adenosine has been shown to decrease channel sensitivity to the inhibitory effects of ATP and, acting via A1 and A3 adenosine receptors (AR), activate the channel via a Gi protein ([Fig. 3]) [49] [50] [51]. Adenosine may also mobilize PKCξ a kinase linked to increased incorporation of KATP channel subunits into the sarcolemma [52] [53]. However, adenosine may be more effective in regulating atrial than ventricular tissue, as it appears to have little effect on the ventricular AP [54]. Additionally, the effect of TRN on AR is unknown. Clearly, the mechanisms by which TRN increases the sKATP channel content and activation are important topics for future investigation.


TRN-induced increase in CM contractility

The TRN-induced increase in biomechanical function and cardiac efficiency are mediated by a combination of factors, including the increase in CM length, AP regulation of Ca2+ influx, the Ca2+ transient rate of rise and duration, β-AR regulation, increased myofilament Ca2+ sensitivity, and an elevated rate of CM shortening [5] [13] [19] [21] [22] [55]. TRN-induced cardiac hypertrophy and, in resting CM, a prolonged APD and Ca2+ transient facilitates an increased stroke volume and reduced HR at a given CO producing a more efficient heart [9] [10] [19] [38] [56]. Cardiac hypertrophy appears to be primarily due to a TRN-induced increase in CM cell length [19] [57], but Natali et al. [21]. did observe TRN to increase CM width and peak tension. This adaptation was associated with an increased steepness in the tension-length relationship which would contribute to an increased SV. In agreement with Moore et al. [58] and Wisløff and colleagues [56] [59], we found wheel running in rats to increase CM shortening velocity and the rate of rise of the intracellular Ca2+ transient ([Fig. 4]) [22]. Our results extended the previous findings to show that these adaptations occurred in CM isolated from both the apical (primarily epicardial CM) and basal (primarily endocardial CM) regions of the heart in both sexes [22]. The mechanism for the TRN-induced increase in shortening velocity is unknown. A possibility may be that it could reflect an increased myofibril ATPase as this enzyme has been shown to regulate shortening velocity [60]. However, Baldwin et al. [61] [62] found only a transient increase in this enzyme with endurance treadmill running in rats. It is unknown how TRN increases the rate of rise in the CM Ca2+ transient. An untested possibility is that TRN might increase the number, open probability, or activation rate of the SR ryanodine receptor [63]. Alternatively, SR Ca2+ release is known to be dependent on SR Ca2+ content; so, TRN might increase the rate of Ca2+ release by shifting the SR Ca2+ content-SR Ca2+ release relationship to favor release at a given SR Ca2+ content [63] [64]. In the resting state, the TRN-induced prolongation of the APD would allow the sarcolemma L-type Ca2+ channel to remain open longer, thus facilitating Ca2+ influx and activation of Ca2+ induced SR Ca2+ release. This factor could contribute to a faster onset of the Ca2+ transient in resting, unstressed CM, but not during exercise, as TRN shortens the APD, which would close the L-type Ca2+ channel sooner reducing Ca2+ influx. Additionally, TRN has been shown to have no effect on L-type Ca2+ channel number or current, which decreases the likelihood that it mediates TRN-induced changes in the Ca2+ transient [65].

Zoom
Fig. 4 Exercise training and isoproterenol (ISO) effect on sarcomere shortening rate. Left: representative cardiomyocyte sarcomere shortening (a) and Ca2+ transient traces (b) at 37°C with 1-Hz stimulation. Best-fit lines are shown to demonstrate the measurement of sarcomere shortening and relaxation rates. Right: in the absence and presence of β-agonist, exercise training (TRN) increased sarcomere shortening velocity compared to the sedentary (SED) group. The addition of 5 nM ISO increased sarcomere shortening velocity in both SED and TRN groups. One micromolar ISO had a larger effect than 5 nM ISO on shortening velocity in the TRN group but not in SED. *P=0.05, TRN group vs. SED group; **P=0.05, 5 nM ISO vs. no ISO; †P=0.05, 1 µM ISO vs. 5 nM ISO. Source: Am J Physiol Heart Circ Physiol 2018; 315: H885-H896.

TRN not only increased CM shortening velocity but also the extent of shortening, and this occurred in the face of no change or even a decrease in the amplitude of the Ca2+ transient ([Fig. 4]) [18] [19] [56] [58]. A logical explanation for the latter is that TRN increases the Ca2+ sensitivity of the myofilaments [5] [18]. The mechanism of this effect is unknown, but it could involve molecular adaptations in filament proteins ([Fig. 3]). There are multiple studies assessing the importance of phosphorylation of cardiac myosin binding protein C (cMyBP-C), regulatory light chain (RLC), Troponin-I, and phospholamban (PLB) in regulating Ca2+ sensitivity, rate of tension development (Ktr), and the sarcoplasmic reticulum Ca2+ ATPase (SERCA2) pump [66] [67] [68] [69] [70]. For example, phosphorylation of RLC and cMyBP-C are known to move the myosin head toward the actin binding site, increasing Ca2+ sensitivity and cross-bridge kinetics ([Fig. 3]) with phosphorylation of RLC and cMyBP-C having the greatest effect on Ca2+ sensitivity and Ktr, respectively [68] [71] [72] [73] [74]. It is unknown whether TRN increases Ktr, the content or phosphorylation of RLC or cMyBP-C. However, Diffee and Nagle [4] showed that TRN increased CM Ca2+ sensitivity at long but not short sarcomere lengths, which suggests that the effect is most noticeable when filament spacing is reduced. Phosphorylation of RLC is known to move the myosin filament closer to the actin filament increasing Ca2+ sensitivity, and this may be the mechanism by which TRN increases Ca2+ sensitivity. We observed TRN to have no effect on CM relaxation under basal conditions but accelerate relaxation in response to β-AR agonist [22]. In contrast, Kemi et al. [18] and Wisløff et al. [56] observed a TRN-induced acceleration of relaxation at all activation frequencies from 2 to 10 Hz, with HIIT having a greater effect than MICT. The accelerated relaxation was likely caused by a 25% upregulation of SERCA2 and PLB ([Fig. 3]) [56]. For the most part, the effects of TRN on key myofilament proteins ([Fig. 3]) and how they alter biomechanical properties of the CMs is unknown.


Role of β-adrenergic agonist and adenosine in mediating TRN-induced adaptations in CM function

The heart is controlled by the autonomic nervous system with HR and contractility regulated by the degree of parasympathetic versus sympathetic tone. It is well established that TRN increases parasympathetic and decreases sympathetic tone in the resting individual, which contributes to the reduced resting HR [75] [76]. With the onset of exercise, sympathetic tone increases and acting primarily through β1-AR increases PKA, which accelerates contraction and relaxation by phosphorylating cMyBP-C, troponin I, the ryanodine receptor and PLB ([Fig. 3]) [68] [73] [75]. As reviewed above, sympathetic activation acting via the β1-AR is important in the activation of the Iks channel and this response is down regulated by TRN [19]. This effect was not caused by a decline in β1-AR content but rather to a reduced Ik channel protein and the kinase anchoring the protein Yotiao [25]. In the face of a maintained β1-AR number, TRN upregulated the contractile response of CMs to adrenergic agonist [22]. As little as 5 nM of isoproterenol increased the amount of sarcomere shortening and relaxation rate, and the response was greater than that observed in the sedentary group ([Fig. 4]) [22]. A possible explanation for the TRN-induced increase in the contractile response to adrenergic agonist is TRN downregulated β-adrenergic receptor kinase 2 (GRK2), which would reduce inactivation of the β-AR, thus maintaining higher PKA and contractility ([Fig. 3]) [25]. The down regulation of GRK2 may be particularly important in heart failure, as lowering this protein has been shown to reverse dysfunction of both the β1-AR and β2-AR, and decrease the high sympathetic nervous system activity associated with heart failure [77].

Regulation of mammalian cardiac muscle contractility is complex and depends on multiple factors including the ratio of parasympathetic/sympathetic tone, and the content and activation of adrenergic and adenosinergic receptors [75] [76] [78]. Besides the three β-receptor subtypes (β1-R, β2-R, and β3-R), mammalian CMs express four adenosine receptors A1AR, A2aAR, A2bAR, and A3AR [79]. The primary inotropic receptors are the β1-R and the A2aAR, and while both increase the extent and rate of CM shortening, only β1-R increases the rate of CMs relaxation [8] [78]. Importantly, the extent of contractile enhancement resulting from β1-R activation can be altered by adenosine receptor activation. For example, activation of A1AR reduces CM contractility via an anti-adrenergic effect, while A2a and A2b both increase contractility ([Fig.3]) [8] [78] [79]. The A2bAR is thought to have a direct effect on the myofilaments while A2aAR acts indirectly by modulating the A1AR effects [79]. To our knowledge, there is no information on whether TRN alters the CMs response to adenosine, the interplay between adrenergic and adenosinergic stimulation or the AR content for any of the four receptor subtypes. These are important factors to consider, as TRN-induced changes in AR content or adenosine interaction with β1-R activation would have direct effects on the KATP channel (A1 and A3) and contractility (A1, A2a, and A2b) ([Fig. 3]).


Mechanisms by which TRN protects the heart from ischemic injury and heart failure

Cellular effects of reperfusion injury and TRN-induced protection

It is well known that TRN protects the heart form ischemia and reperfusion (IR) injury, and while there are multiple theories on potential mechanisms, to date no unifying concept has emerged [3] [80] [81]. The degree of protection is related to the amount of activity, and while not definitively tested, HIIT seems to protect better than MICT [11] [12] [82]. The prognosis following an acute myocardial infarct (AMI) and the likelihood of progressing to heart failure is directly related to the extent of CM cell death [83]. Heart injury with AMI is exacerbated by IR, and in vivo and ex vivo animal models of IR show that TRN results in a 30 to 40% reduction in IR-induced CMs cell death [81] [84] [85]. The observation that protection due to TRN exists in ex vivo hearts suggests that it is at least, in part, mediated by adaptations in cell/molecular factors innate to the heart. The cellular effects of IR have been extensively reviewed [3] [80] [81] and they include reduced ATP, increased glycolysis, low pH, increased production of reactive oxygen species (ROS), activation of Ca2+ activated proteases, impaired energy dependent ionic pumps, and increased intracellular Ca2+ (iCa2+) and mitochondrial Ca2+ (mCa2+); all of which could contribute to reduced cardiac function. IR injury has been attributed to increased ROS production, and the protective effects of TRN to increased production of antioxidants that limit oxidative stress and damage to proteins, such as myofilaments and SR [3] [80] [86]. Clearly, ROS production can be an important mediator of IR injury, but disruption in iCa2+ regulation resulting in mCa2+ overload and apoptosis seems likely to be a key factor in orchestrating IR injury. Support for this idea comes from the demonstration that activation of the sKATP channel is critical to protecting the heart from IR injury and that the beneficial effects of TRN are in part due to the upregulation and activation of the sKATP channel [7] [33]. Knock-out or pharmacological inhibition of the sKATP channel eliminates the TRN-induced protection form IR injury [7] [33]. Presumably, protection from IR injury in hearts of trained individuals is initiated by the early and rapid repolarization of the sarcolemma that results from outward K+ current through the sKATP channel closing the L-type Ca2+ channel and limiting Ca2+ influx ([Fig. 3]) [25] [82]. Rat data suggests that TRN may induce greater protection from IR-injury in females than males, and that this relates to a greater incorporation of the sKATP channel subunits into the sarcolemma [87]. It has been suggested that this sex effect is mediated by PKCξ and that it can be blocked by ovariectomy and PKCξ blockers [53] [88].


Comparison of TRN with preconditioning/postconditioning

Besides TRN, brief periods of ischemia and reperfusion, preceding deleterious IR (ischemic preconditioning, IPC) and at the onset of reperfusion (postconditioning, POC), have been shown to reduce IR-induced CM cell death [7] [87] [89] [90]. In 1986, Murry et al. [89] were the first to discover IPC, while Zhao et al. [90] discovered POC and compared it to IPC. All except TRN, have a limited period of protection; so while IPC and POC have clinical value, they cannot be used to limit heart damage due to AMI. The mechanisms by which these modalities protect the heart are not completely defined, but it seems likely that some of the same signaling pathways, substrates and enzymes induced by TRN may also be triggered by IPC and POC. Frasier et al. [81] suggests that while TRN and IPC may utilize some common features, the mechanisms are not the same, as IPC seems to involve the PI3K-Akt-GSK3β pathway, while increases in pAkt and pGSK3β are not involved in the TRN-induced protection from IR-injury. However, that conclusion may not be appropriate, as we noted above whereby TRN does increase pAkt and pGSK3β [39]. Thus protection could result from pGSK3β increasing the open probability of the sKATP channel, and by inhibiting ER protein inositol 1,4,5-trisphosphate receptor (IP3R) release of ER Ca2+, thus preventing mCa2+ overload [39] [40] [41]. The increased sKATP open probability could be aided by a TRN-induced increase in BDNF [42]. Support for this comes from the observation that BDNF knock-out mice showed increased CM cell death and left ventricular dysfunction following IR compared to the wild type control [91]. It is established that IPC and TRN have some overlapping signaling pathways, and evidence that they may converge on the same target in protecting against IR injury is based on the finding that IPC plus TRN did not produce greater protection than either treatment alone (unpublished data).


Importance of mitochondria associated membrane and its role in mediating TRN-induced cardioprotection from IR injury

While the causative events in IR- induced CM injury and death are not well established, mitochondria-triggered apoptosis is thought to be a final event leading to CM death [92] [93]. Important to the structural and functional integrity of the CM is the mitochondria-endoplasmic reticulum (SR/ER) network, also known as the mitochondria associated membrane (MAM). The MAM constitutes a complex of molecular tethers that associates the outer mitochondrial membrane (OMM) with the ER ([Fig. 3]), which mediate interorganelle communications [93] [94]. Functionally, the MAM facilitates lipid and Ca2+ exchange between mitochondria and ER. This anatomical and functional coupling is the hub for the integration of mitochondrial function during normal cell physiology and the preservation of life during stress [95]. Mitochondria, are a major hub for Ca2+ handling and are central in energy metabolism, and the MAM domain provides a crucial link between ER Ca2+ signaling and the control of cellular energy demand by regulating mitochondrial bioenergetics [92] [94]. Dysregulation of ER-mitochondria (MAM) crosstalk is known to alter cardiac physiology and is implicated in cardiac IR injury. As noted above, and also well reported, one of the salient hallmarks of cellular damage by IR is iCa2+ and mCa2+ overload. Indeed, mCa2+ overload due to disruption of ER-mitochondria crosstalk in the MAM domain is implicated in the formation of the deleterious and permanent mitochondrial permeability transition pore (mPTP) opening and CM death [92] [93] [96] [97]. Deleterious mPTP opening following oxidative stress, mCa2+ overload or combination of both, has been reported as a trigger for IR injury or AMI [92] [98] [99] [100] [101]. As alluded to previously, it is well known that the benefits of TRN encompass adaptations in heart and CM function as well as other systems that have secondary beneficial effects on cardiac efficiency [3] [10] [102] [103]. TRN is known to be a powerful way to protect the heart from ischemic stress [3] and while untested, our hypothesis is that TRN preserves MAM Ca2+ homeostasis and protects against mCa2+ overload to preserve mitochondrial function during IR. Therefore, TRN regulating ER/-mitochondrial Ca2+ homeostasis in the MAM domain could represent a novel feature, biochemically and biophysically, in mediating cardioprotection against injury by ischemic stress.

The MAM domain contains numerous transport proteins and signaling molecules that act as a platform for multiple physiological functions, as well as the regulation of cytosolic Ca2+ homeostasis. In the CM MAM domain, the chaperone protein glucose-regulated protein 75 (GRP75), the ER protein IP3R for Ca2+++release, and the voltage-dependent anion channel 1 (VDAC1) in the OMM form the IP3R-GRP75-VDAC1 complex that regulates the direct transfer of Ca2+ from the ER to mitochondria ([Fig. 3]) and regulates cytosolic Ca2+ [96] [104] [105] [106] [107]. Under normal physiological conditions, the ER-mitochondria interaction via domain [Ca2+] provides the necessary physiological coupling between muscle contraction/relaxation and the required mitochondrial ATP necessary for muscle function [108]. The MAM complex is also modulated biochemically by hexokinase II (HKII), and the signaling molecules Akt and the serine/threonine kinase GSK3β further regulate domain Ca2+ during IR injury or cytoprotection against IR stress [109] [110] [111]. Regarding cardioprotection, a crucial cell survival strategy involves HKII association with VDAC1 [110] [112] [113]. For example, in cancer cells, HKII translocates at the MAM and its displacement from MAM triggers mCa2+ overload following IP3R opening [114] [115]. We also reported that hypothermic cardioprotection against acute IR led to increased Akt and phosphorylation of Akt, and HKII association with VDAC1 [112]. During cardiac ischemic stress, the increase in GSK3β activity leads to the phosphorylation of IP3R, and to the transfer of excess Ca2+ from the ER to mitochondria via the IP3R-GRP75-VDAC1 complex [116]. Furthermore, during ischemic stress, it is reported that GSK3β phosphorylation of VDAC1 reduces HKII binding to VDAC1 and abrogates its protection [92] [110] [117]. Thus, disruption of the ER-mitochondria interaction in the MAM region or inhibition of GSK3β during reperfusion has been shown to protect and preserve CMs from IR injury [107] [116] [118] [119]. Importantly, TRN has been shown to increase Akt activity and inhibit GSK3β activity by phosphorylation (pGSK3β), leading to stimulation of cardiac hypertrophy [10] [39]. As discussed above, TRN is known to activate the PI3K/Akt signaling pathway and increase pAkt [120] [121] [122]. Consistent with these findings, we have shown in pilot studies (unpublished data) that TRN increased total Akt (tAkt), phospho-Akt (pAkt), and pGSK3β after IR, suggesting that the TRN-induced inhibition of GSK3β may decrease the IP3R-induced aberrant MAM Ca2+ release. These observations strongly implicate the role of MAM proteins in modulating TRN-induced cardioprotection against IR-mediated dysregulation of Ca2+ dynamics and homeostasis. Whether TRN-induced protection against IR injury involves adaptation of MAM Ca2+ handling, and whether this adaptation leads to decreased mCa2+ overload by the activation of the PI3K/Akt/GSK3β signaling axis during ischemic stress remains to be fully explored. A better understanding of the underlying molecular mechanisms of how TRN regulates MAM Ca2+ handling, minimizes mCa2+ overload, and preserves mitochondrial function during IR stress represents an innovative approach that may contribute to the development of optimal TRN protocols that lead to long-term protection of cardiac viability and function.



Impact of life-long exercise on incidence of atrial fibrillation

Programs of regular exercise (TRN) are known to promote cardiovascular health, reduce conditions associated with heart disease, such as obesity and type 2 diabetes, and increase longevity [3] [10] [123]. Despite these known benefits, recently there has been considerable discussion on whether chronic life-long TRN can lead to detrimental cardiovascular effects and, in particular, to an increased incidence of atrial fibrillation (AF) [124] [125] [126]. The majority of AF patients are over the age of 65 [127], and interestingly, the incidence of AF has been reported to be 2 to 10-fold higher in life-long exercisers, with the risk increasing based on the total hours and number of years of TRN [123] [124]. This observation has led to the hypothesis that TRN beyond a certain threshold may not produce additional benefits and could be detrimental to cardiovascular health such that the benefits of life-long TRN may show a reversed j-shaped dose-response curve, where chronic moderate-intensity/duration TRN reduces the risk of AF and chronic high-intensity/duration TRN increases this risk [125] [128]. The causes for the age-related increase in AF are poorly understood, but a portion of the increase occurs in concert with other health issues, such as diabetes and coronary artery disease, that place the heart in a condition susceptible to arrythmias [129]. There are also changes in sarcolemma channel function with aging, such as a reduced L-type Ca2+ current and slowed conduction velocity, that might facilitate AF [129]. TRN reduces heart disease and diabetes, and has no effect on L-type Ca2+ channel [10] [65]. So the question is why does AF show a higher incidence with life-long TRN? This question remains unanswered, but its etiology is likely heterogeneous, i. e. relating to structural and electrophysiological changes [123] [126] [130]. TRN increases the ratio of parasympathetic/sympathetic tone and the size of all four chambers, and it has been suggested that either or both increase the risk of AF [123]. However, this cannot be the only explanation, as increases in vagal tone and heart hypertrophy occur early with the onset of TRN when there are no electrical changes in the heart or an increased risk for AF [126] [131]. TRN has been reported to increase left atrial (LA) volume more than left ventricular (LV) volume [126], and this disproportionate increase in LA volume was shown to be an independent predictor of AF [127]. Life-long TRN has also been shown to increase myocardial fibrosis and coronary artery calcification (CAC), factors linked to AF [1] [128]. Athletes with high life-long TRN volumes had higher CAC scores than those who TRN with low volume; however, the high volume group showed mostly calcified atherosclerotic plaques that were benign, with lower risk for cardiovascular disease, including AF [132]. While a TRN-induced increase in myocardial fibrosis seems to increase with the amount of TRN and could contribute to a slower conduction velocity, the incidence is low and its relationship to AF is unknown [128]. It seems reasonable to suggest that the combination of age-related changes in heart function coupled with the TRN-induced increase in vagal tone, LA volume, and myocardial fibrosis could contribute to the increased AF in individuals who maintain a high degree of TRN for multiple years. Support for this notion comes from the study of Wilhelm et al. [133], who stratified athletes according to training hours as low (+<+1,500 hrs), medium (1,500 to 4,500 hrs), high (+>+4,500 hrs), and very high (+>+20,000 hrs) and observed a progressive increase with TRN hours in P-wave duration, LA volume, vagal tone, and premature atrial contractions.

The question remains, what is the primary driver for the increased incidence of AF with life-long high intensity TRN? We hypothesize that the TRN-induced changes in K+ channel function, specifically a downregulation in the Iks and upregulation of the sKATP channels that allow the heart to adjust the APD to meet the metabolic demand and provide protection from ischemia (reviewed above), also contribute and may in fact be the primary drivers for the increased incidence of AF in older life-long exercisers. AF is characterized by a shortening of the APD and the atrial refractory period (ARP). Gonzalez et al. [134] showed that the Iks was markedly increased in chronic AF patients due to upregulation of β-AR, which contributed to the abbreviated APD and ARP and to the maintenance of AF. This mechanism cannot explain the increased incidence of AF in chronically TRN older adults compared to their sedentary counterparts, as TRN downregulates the Iks channel and its regulation by β-AR [25]. However, the increased AF in chronically TRN individuals could be mediated by the TRN-induced increase in the sKATP channel. Balana et al. [135] hypothesized that an increase in the sKATP channel content or activation would reduce the APD and contribute to chronic AF. However, what they observed was the opposite as myocytes from AF patients showed markedly reduced sKATP channel density. The authors concluded that the downregulation of the sKATP channel was a secondary compensation mechanism to prolong the APD and ARP to help reduce AF. This protective mechanism would be muted in chronically TRN individuals where the sKATP channel is upregulated [22]. While the sKATP channel is not open during resting, non-stressed conditions in young individuals, this may not be true of older adults, where stress maybe increased and activate the channel even in a resting, non-exercising individual [124]. Additionally, TRN not only increases sKATP content but it may also increase the likelihood of sKATP activation ([Fig. 3]).

It is important that life-long exercisers are aware of their increased susceptibility to AF so that they along with their family physician can track their heart health. It is also important to realize that despite an increased incidence of AF, life-long TRN reduces the risk of stroke and heart failure likely because of other beneficial effects of TRN, such as reduced diabetes, increased coronary circulation, and improved contractility [129]. The increased risk of AF is not a reason to become less active as data shows that for every MET (metabolic equivalent of task where one MET is the amount of energy used while sitting quietly) of exercise+>+4 METS there is a 12–20% reduction in cardiovascular mortality [123]. Simply put, life-long exercisers live longer than those with a sedentary life style.


Limitations in our current knowledge/future studies

While the value of TRN in promoting cardiovascular health is well documented, and major progress has been made in understanding the cellular and molecular mechanisms, considerable gaps in our knowledge still exist [10]. Relating to this review, the mechanism of the TRN-induced increased expression, sarcolemma incorporation, and activation of the sKATP channel is not well understood. The extent to which it involves the PI3K-Akt-GSK3β pathway producing an increase in pAkt and pGSK3β, increases in AMPK or BDNF, and/or adenosine regulation of the channel needs to be explored ([Fig. 3]).

As reviewed above, TRN increases CM contractility, and this is, in part, due to an increased response to adrenergic agonist [22]. The regulation of CM contractility is complex, and almost nothing is known about how TRN alters adenosine’s effect on contractility or its interaction with adrenergic activation. Down field from these events, it is unclear how TRN increases fiber ATPase and Ca2+ sensitivity or whether it alters the functional states of the cross-bridge or kinetics of tension development (ktr) [136] [137]. Resolving these questions will require a detailed analysis of TRN-induced changes in content and phosphorylation level of the key contractile proteins, such as RLC, cMyBP-C, troponin, titin, etc. ([Fig. 3]), and the ability to separate out how a change in each contractile protein alters function.

Another important unresolved question is understanding what role TRN plays in regulating MAM Ca2+ handling and minimizing mCa2+ during IR, and elucidating the mechanism of these effects. Finally, working out the mechanisms of how life-long TRN increases AF is an important yet difficult problem. Longitudinal studies assessing cardiac function are problematic and unlikely to provide definitive answers, and obtaining atrial tissue from sedentary and life-long exercisers in the appropriate numbers to study sarcolemma channel function will be difficult. A novel approach would be to produce iPSC-CM from skin, blood, or urine of sedentary and life-long exercisers. This approach would allow a detailed assessment of channel function and the role of the sKATP channel in the induction of arrythmias.


Conclusion

The beneficial effects of regular exercise (TRN) are well known and include both systemic and cellular adaptations. While controversy exists regarding the importance of HIIT versus MICT, the preponderance of evidence suggests that the former provides certain advantages to cardiac patients by inducing increases in left ventricular ejection fraction and isovolumetric relaxation, and by stimulating a greater increase in aerobic power. An important sarcolemma adaptation with TRN is the downregulation of the Iks and upregulation of the sKATP channels, which results in a prolonged APD at rest due to reduced Iks activation and current and a shortened APD with exercise/stress due to increased sKATP channel content and current. Important TRN-induced adaptations in contractility include a faster rise in the Ca2+ transient, and faster and greater CM shortening. The greater CM shortening occurred with no change in the amplitude of the Ca2+ transient suggesting that TRN increased Ca2+ sensitivity.

IR injury has been attributed to ROS production and the protective effects of TRN to increased production of antioxidants. While ROS production seems to be involved, disruption in iCa2+ regulation resulting in mCa2+ overload and apoptosis seems likely to be a key factor in orchestrating IR injury. Support for this notion comes from the well-established observation that the TRN-induced increase in the sKATP activation is critical in protecting the heart from IR injury and that blockage of this channel removes the protection. Opening of the sKATP channel depolarizes the CM and closes the L-type Ca2+ channel, reducing iCa2+ and mCa2+. The TRN-induced increase in pGSK3β not only participates in the activation of the sKATP channel but may also decrease the IP3R-induced aberrant MAM Ca2+ release during IR and protect the mitochondria from Ca2+ overload and cell death. Finally, chronic life-long TRN is linked to a ~5-fold increase in AF compared to sedentary older adults. Importantly, despite this, life-long TRN is known to improve cardiovascular function, reduce IR injury, and promote longevity.



Conflict of Interest

The authors declare that they have no conflict of interest.


Correspondence

Dr. Robert Fitts
Marquette University
Biological Sciences
1428 W Clybourn street
53233–1881 Milwaukee
United States   
Phone: 414–350–6859   

Publication History

Received: 19 December 2023

Accepted: 18 March 2024

Article published online:
22 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany


Zoom
Fig. 1 Overlapping representative action potential traces from apex and base myocytes in sedentary (SED) and exercise-trained (TRN) female rats. Action potential durations (APD) measured at 90% repolarization of the action potential (APD90) in apex and base myocytes show a regional difference, with APD90 of base myocytes (representative of endocardial cells) significantly longer than apex myocytes (representative of epicardial cells). The APD90 values for both are significantly prolonged by exercise training. Measurements were obtained at room temperature with 1-Hz stimulation.
Zoom
Fig. 2 Representative action potential traces highlighting high stimulation rate (10 Hz) induced shortening of action potential duration (APD) measured at 90% repolarization of the action potential (APD90) compared to 1 Hz stimulation (left) and exercise-training effect at 10 Hz (right). At 10 Hz, APD90 was shortened more in myocytes from exercise-trained (TRN) than sedentary (SED) rats.
Zoom
Fig. 3 Schematic of key cardiomyocyte components, including the sarcolemma, myofibrils, sarcoplasmic reticulum, and mitochondria, and adaptations with exercise-training (TRN). Downward and upward arrows indicate a TRN-induced decrease and increase, respectively, in proteins or physiological conditions. The downward arrows for ICa,L and cytosolic Ca2+ refer to less of an increase in TRN compared to sedentary (SED) during stress. Abbreviations: AP, action potential; IKATP, outward repolarizing potassium current through the KATP channel; IKS, outward repolarizing potassium current through the slowly activating, delayed rectifier potassium channel; ICa,L, current thru the L-type Ca2+ channel; A1, A2a, A2b, A3; adenosine receptor isoforms; β1, beta adrenergic receptor; Gs, stimulatory G protein; Gi, inhibitory G protein; GRK2, G-protein-coupled receptor kinase 2; PKA, protein kinase A; AMPK, AMP-activated protein kinase; pGSK3β, phosphorylated glycogen synthase kinase-3β; pAkt, phosphorylated protein kinase B; VDAC1, voltage dependent anion channel 1; GRP75, glucose-regulated protein 75; SERCA, sarco/endoplasmic reticulum Ca2+ ATPase pump; MyBP-C, myosin binding protein C; RLC, regulatory light chain; IP3R, IP3 receptor. Figure created using Microsoft PowerPoint.
Zoom
Fig. 4 Exercise training and isoproterenol (ISO) effect on sarcomere shortening rate. Left: representative cardiomyocyte sarcomere shortening (a) and Ca2+ transient traces (b) at 37°C with 1-Hz stimulation. Best-fit lines are shown to demonstrate the measurement of sarcomere shortening and relaxation rates. Right: in the absence and presence of β-agonist, exercise training (TRN) increased sarcomere shortening velocity compared to the sedentary (SED) group. The addition of 5 nM ISO increased sarcomere shortening velocity in both SED and TRN groups. One micromolar ISO had a larger effect than 5 nM ISO on shortening velocity in the TRN group but not in SED. *P=0.05, TRN group vs. SED group; **P=0.05, 5 nM ISO vs. no ISO; †P=0.05, 1 µM ISO vs. 5 nM ISO. Source: Am J Physiol Heart Circ Physiol 2018; 315: H885-H896.